SCHEMBL13409356

SCHEMBL13409356

CC(C)Oc1ccnc2cc(Cl)ccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
NR4A2 P43354 2/20 0.54
SOS2 Q07890 1/20 0.51
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GLA P06280 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
CYP1A2 P05177 1/20 0.46
HSD17B10 Q99714 2/20 0.46
GAK O14976 1/20 0.46
POLB P06746 1/20 0.45
THRB P10828 1/20 0.45
CHKA P35790 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CCR1 P32246 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1702115 0.83 LMNA (0.61) LMNASMN1; SMN2NR4A2SOS2MAPT
SCHEMBL2608853 0.81 LMNA (0.53) LMNASMN1; SMN2NR4A2SOS2MAPT
SCHEMBL7529202 0.81 NR4A2 (0.59) LMNASMN1; SMN2NR4A2SOS2MAPT
SCHEMBL9431519 0.81 SLC6A4 (0.48) LMNASMN1; SMN2NR4A2SOS2MAPT
SCHEMBL28641518 0.80 LMNA (0.52) LMNASMN1; SMN2NR4A2SOS2MAPT
SCHEMBL12762533 0.79 HTR1A (0.52) GAK
SCHEMBL10377143 0.79 POLB (0.63) LMNASMN1; SMN2NR4A2SOS2MAPT
SCHEMBL9430990 0.79 SLC6A4 (0.50) LMNASMN1; SMN2NR4A2SOS2POLB
SCHEMBL9430702 0.79 SLC6A4 (0.50) LMNASMN1; SMN2NR4A2SOS2POLB
SCHEMBL9430602 0.79 SLC6A4 (0.50) LMNASMN1; SMN2NR4A2SOS2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105037266-A Antibacterial chloroxoquinoline derivative WANG ZIHOU 2015-11-11 CN claimed
CN-105017145-A Chloroxoquinoline derivative with anti-tumor activity WANG ZIHOU 2015-11-04 CN claimed
CN-105037266-A Antibacterial chloroxoquinoline derivative WANG ZIHOU 2015-11-11 CN disclosed
CN-105017145-A Chloroxoquinoline derivative with anti-tumor activity WANG ZIHOU 2015-11-04 CN disclosed
CN-103864681-B Chloroxoquinoline derivatives for antibacterial use WANG ZIHOU (CN) 2015-09-02 CN disclosed
CN-103864680-B Chloroxoquinoline derivative with antineoplastic activity WANG ZIHOU (CN) 2015-09-02 CN disclosed
CN-103864680-A Chloroxoquinoline derivative with antineoplastic activity WANG ZIHOU 2014-06-18 CN disclosed
CN-103864681-A Chloroxoquinoline derivatives for antibacterial use WANG ZIHOU 2014-06-18 CN disclosed
US-7705146-B2 Hepatitis C inhibitor peptide analogs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-27 US disclosed
US-7705146-B2 Hepatitis C inhibitor peptide analogs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-27 US disclosed